Develops and manufacturers multispectral digital scanners based upon a patented flatbed scanner design.

Oxford Nanoimaging’s microscope, the Nanoimager, is a single-molecule fluorescence microscope.
It is about 30 times smaller and significantly less expensive than current super-resolution microscopes and will be manufactured in the UK.

Oxford Nanopore Technologies is developing and commercialising a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins.

Developing novel catalyst process and route to high value internal olefins.

Oxford PV are developing new photovoltaic cells that will provide a sustainable solar energy source.

Developing superconducting circuit quantum computing.

Oxford Risk is the market-leading provider of customer risk profilers. Their products reveal the level of risk customers are willing and able to take with their financial investments.

Developing RDFox, the world’s most powerful market-ready knowledge graph and semantic reasoner.

Produce non-replicating bacterial cells for a variety of healthcare applications.

Catalyst production and processes for upgrading pyrolysis oil to high octane gasoline.

Cellular immunity vaccines.

Virtual Reality software to help treat people with severe paranoia by allowing them to face situations that they fear.

Provide an environmentally-responsible method of controlling disease spreading pests.

GPS tracking and monitoring technology.

To bring the tools developed for heritage to the management of healthcare data.

Next generation of high performance alloys.

Cancer diagnostics.

Advanced materials business which licences patents related to nanomaterials.

Maritime trade and transport simulation.